A systematic review and meta-analysis of randomized controlled trials, juxtaposing the control of glycemia and blood pressure between large dose empagliflozin and placebo among type 1 diabetes patients.

Keywords : ['placebo among type diabete patient', 'randomize control trial juxtapose', 'large dose empagliflozin', 'systematic review', 'blood pressure', 'control', 'metaanalysis', 'glycemia']
Author : Fist_Author_Year_PM
16

The comparison of efficacy and safety between different doses of empagliflozin in insulin-treated type 1 diabetes mellitus patients: a systematic review and meta-analysis protocol.

Keywords : ['insulintreated type diabete mellitus patient', 'systematic review', 'metaanalysis protocol', 'different dose', 'safety', 'empagliflozin', 'efficacy', 'comparison']
Author : Fist_Author_Year_PM
16

Role of novel sodium glucose co-transporter-2 inhibitor enavogliflozin in type-2 diabetes: A systematic review and meta-analysis.

Keywords : ['novel sodium glucose inhibitor enavogliflozin', 'systematic review', 'role', 'metaanalysis', 'diabete']
Author : Fist_Author_Year_PM
16

Exploring the comparative cardiovascular death benefits of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a frequentist and Bayesian network meta-analysis-based scoring.

Keywords : ['comparative cardiovascular death benefit', 'bayesian network metaanalysisbase scoring', 'sodiumglucose cotransporter inhibitor', 'type diabete', 'frequentist', 'explore']
Author : Fist_Author_Year_PM
16

Sodium-glucose cotransporter 2 inhibitors and fracture risk in patients with type 2 diabetes mellitus: A systematic literature review and Bayesian network meta-analysis of randomized controlled trials.

Keywords : ['type diabetes mellitus', 'systematic literature review', 'sodiumglucose cotransporter inhibitor', 'randomize control trial', 'bayesian network metaanalysis', 'fracture risk', 'patient']
Author : Fist_Author_Year_PM
15

Cardiovascular outcomes, heart failure and mortality in type 2 diabetic patients treated with glucagon-like peptide 1 receptor agonists (GLP-1 RAs): A systematic review and meta-analysis of observational cohort studies.

Keywords : ['glucagonlike peptide receptor agonist ras', 'type diabetic patient treat', 'cardiovascular outcome heart failure', 'observational cohort study', 'systematic review', 'mortality', 'metaanalysis']
Author : Fist_Author_Year_PM
16

Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trials.

Keywords : ['randomise control trial', 'type diabete', 'insulin analogue', 'baseline change', 'target', 'relationship', 'metaanalysis']
Author : Fist_Author_Year_PM
17

Common polymorphism near the MC4R gene is associated with type 2 diabetes: data from a meta-analysis of 123,373 individuals.

Keywords : ['type diabete datum', 'common polymorphism near', 'metaanalysis', 'individual', 'gene', 'associate']
Author : Fist_Author_Year_PM
16

A comparison of biphasic insulin aspart and insulin glargine administered with oral antidiabetic drugs in type 2 diabetes mellitus--a systematic review and meta-analysis.

Keywords : ['type diabete mellitusa systematic review', 'oral antidiabetic drug', 'insulin glargine administer', 'biphasic insulin aspart', 'metaanalysis', 'comparison']
Author : Fist_Author_Year_PM
16

Population specific impact of genetic variants in KCNJ11 gene to type 2 diabetes: a case-control and meta-analysis study.

Keywords : ['population specific impact', 'type diabete', 'metaanalysis study', 'genetic variant', 'gene', 'casecontrol']
Author : Fist_Author_Year_PM
16